questionsmedicales.fr
Facteurs biologiques
Protéines et peptides de signalisation intercellulaire
Cytokines
Interleukines
Interleukine-9
Interleukine-9 : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Tests de laboratoire
Interleukine-9
Interleukine-9
Inflammation
Symptômes
5
Asthme
Réactions allergiques
Interleukine-9
Hyperréactivité bronchique
Troubles gastro-intestinaux
Interleukine-9
Démangeaisons
Difficultés respiratoires
Prévention
5
Prévention des maladies
Allergènes
Éducation des patients
Allergies
Alimentation
Inflammation
Contrôle environnemental
Allergènes
Traitements
5
Antihistaminiques
Interleukine-9
Anticorps monoclonaux
Asthme
Corticostéroïdes
Interleukine-9
Bronchodilatateurs
Asthme
Immunothérapie
Interleukine-9
Complications
5
Exacerbations d'asthme
Réactions allergiques
Maladies auto-immunes
Interleukine-9
Surinfections
Interleukine-9
Complications pulmonaires
Fibrose
Troubles cardiovasculaires
Interleukine-9
Facteurs de risque
5
Antécédents familiaux
Asthme
Pollution de l'air
Interleukine-9
Infections respiratoires
Interleukine-9
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Interleukine-9 : Questions médicales les plus fréquentes",
"headline": "Interleukine-9 : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Interleukine-9 : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Interleukine-9"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Interleukines",
"url": "https://questionsmedicales.fr/mesh/D007378",
"about": {
"@type": "MedicalCondition",
"name": "Interleukines",
"code": {
"@type": "MedicalCode",
"code": "D007378",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.529.374.465"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Interleukine-9",
"alternateName": "Interleukin-9",
"code": {
"@type": "MedicalCode",
"code": "D016906",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sushmita Chakraborty",
"url": "https://questionsmedicales.fr/author/Sushmita%20Chakraborty",
"affiliation": {
"@type": "Organization",
"name": "Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India."
}
},
{
"@type": "Person",
"name": "Dipendra Kumar Mitra",
"url": "https://questionsmedicales.fr/author/Dipendra%20Kumar%20Mitra",
"affiliation": {
"@type": "Organization",
"name": "Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India."
}
},
{
"@type": "Person",
"name": "Mattia Matasci",
"url": "https://questionsmedicales.fr/author/Mattia%20Matasci",
"affiliation": {
"@type": "Organization",
"name": "Philochem AG, CH-8112 Otelfingen, Switzerland."
}
},
{
"@type": "Person",
"name": "Dario Neri",
"url": "https://questionsmedicales.fr/author/Dario%20Neri",
"affiliation": {
"@type": "Organization",
"name": "Philochem AG, CH-8112 Otelfingen, Switzerland."
}
},
{
"@type": "Person",
"name": "Katharina F Kubatzky",
"url": "https://questionsmedicales.fr/author/Katharina%20F%20Kubatzky",
"affiliation": {
"@type": "Organization",
"name": "Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University, Heidelberg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Impact of gender mismatch on corneal graft rejection and rejection-related graft failure in repeat penetrating keratoplasty.",
"datePublished": "2022-10-31",
"url": "https://questionsmedicales.fr/article/36315482",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0276043"
}
},
{
"@type": "ScholarlyArticle",
"name": "Graft rejection episodes after keratoplasty in Japanese eyes.",
"datePublished": "2023-02-14",
"url": "https://questionsmedicales.fr/article/36788300",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-29659-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "AIM2 as a putative target in acute kidney graft rejection.",
"datePublished": "2022-09-30",
"url": "https://questionsmedicales.fr/article/36248890",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2022.839359"
}
},
{
"@type": "ScholarlyArticle",
"name": "Epithelial downgrowth leading to graft rejection after penetrating keratoplasty.",
"datePublished": "2022-06-01",
"url": "https://questionsmedicales.fr/article/35651296",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/11206721221106314"
}
},
{
"@type": "ScholarlyArticle",
"name": "COVID-19 Vaccination May Not Increase Rates of Corneal Graft Rejection.",
"datePublished": "2022-08-10",
"url": "https://questionsmedicales.fr/article/35965396",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/ICO.0000000000003101"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines et peptides de signalisation intercellulaire",
"item": "https://questionsmedicales.fr/mesh/D036341"
},
{
"@type": "ListItem",
"position": 4,
"name": "Cytokines",
"item": "https://questionsmedicales.fr/mesh/D016207"
},
{
"@type": "ListItem",
"position": 5,
"name": "Interleukines",
"item": "https://questionsmedicales.fr/mesh/D007378"
},
{
"@type": "ListItem",
"position": 6,
"name": "Interleukine-9",
"item": "https://questionsmedicales.fr/mesh/D016906"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Interleukine-9 - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Interleukine-9",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Interleukine-9",
"description": "Comment mesurer l'interleukine-9 ?\nQuels tests sont utilisés pour le diagnostic ?\nL'IL-9 est-elle liée à des maladies spécifiques ?\nQuels biomarqueurs sont associés à l'IL-9 ?\nL'IL-9 peut-elle être un indicateur de gravité ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Graft+Rejection#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Interleukine-9",
"description": "Quels symptômes sont liés à l'IL-9 ?\nL'IL-9 provoque-t-elle des symptômes respiratoires ?\nY a-t-il des symptômes cutanés associés ?\nL'IL-9 est-elle liée à des symptômes gastro-intestinaux ?\nQuels signes cliniques sont observés ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Graft+Rejection#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Interleukine-9",
"description": "Comment prévenir les maladies liées à l'IL-9 ?\nY a-t-il des vaccins pour l'IL-9 ?\nL'éducation des patients est-elle importante ?\nLes changements alimentaires peuvent-ils aider ?\nLe contrôle de l'environnement est-il crucial ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Graft+Rejection#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Interleukine-9",
"description": "Comment traiter les niveaux élevés d'IL-9 ?\nY a-t-il des thérapies ciblées pour l'IL-9 ?\nLes corticostéroïdes affectent-ils l'IL-9 ?\nQuels médicaments sont utilisés pour l'asthme lié à l'IL-9 ?\nL'immunothérapie aide-t-elle avec l'IL-9 ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Graft+Rejection#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Interleukine-9",
"description": "Quelles complications peuvent survenir avec l'IL-9 ?\nL'IL-9 peut-elle aggraver d'autres maladies ?\nY a-t-il des risques de surinfection ?\nDes complications pulmonaires sont-elles possibles ?\nL'IL-9 est-elle liée à des troubles cardiovasculaires ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Graft+Rejection#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Interleukine-9",
"description": "Quels sont les facteurs de risque pour l'IL-9 ?\nL'exposition à la pollution augmente-t-elle le risque ?\nLe tabagisme influence-t-il l'IL-9 ?\nLes infections respiratoires sont-elles un facteur ?\nLe stress a-t-il un impact sur l'IL-9 ?",
"url": "https://questionsmedicales.fr/mesh/D016906?mesh_terms=Graft+Rejection#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment mesurer l'interleukine-9 ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-9 peut être mesurée par des tests ELISA dans le sérum ou les fluides biologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses de cytokines sont utilisés pour évaluer l'IL-9."
}
},
{
"@type": "Question",
"name": "L'IL-9 est-elle liée à des maladies spécifiques ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 est associée à des maladies comme l'asthme et certaines allergies."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont associés à l'IL-9 ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IL-9 est souvent mesurée avec d'autres cytokines comme l'IL-4 et l'IL-5."
}
},
{
"@type": "Question",
"name": "L'IL-9 peut-elle être un indicateur de gravité ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des niveaux élevés d'IL-9 peuvent indiquer une inflammation sévère."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à l'IL-9 ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des réactions allergiques, de l'asthme et des inflammations."
}
},
{
"@type": "Question",
"name": "L'IL-9 provoque-t-elle des symptômes respiratoires ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 est impliquée dans l'hyperréactivité bronchique et l'asthme."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent survenir dans des conditions allergiques liées à l'IL-9."
}
},
{
"@type": "Question",
"name": "L'IL-9 est-elle liée à des symptômes gastro-intestinaux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 peut être impliquée dans des troubles gastro-intestinaux allergiques."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont observés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent des difficultés respiratoires, des éruptions cutanées et des démangeaisons."
}
},
{
"@type": "Question",
"name": "Comment prévenir les maladies liées à l'IL-9 ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les allergènes et adopter un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des vaccins pour l'IL-9 ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccins spécifiques pour cibler l'IL-9."
}
},
{
"@type": "Question",
"name": "L'éducation des patients est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les patients sur les déclencheurs allergiques est essentiel pour la prévention."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires peuvent-ils aider ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée peut aider à réduire l'inflammation et les symptômes."
}
},
{
"@type": "Question",
"name": "Le contrôle de l'environnement est-il crucial ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, réduire l'exposition aux allergènes environnementaux est essentiel pour la prévention."
}
},
{
"@type": "Question",
"name": "Comment traiter les niveaux élevés d'IL-9 ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements anti-inflammatoires et des antihistaminiques peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies ciblées pour l'IL-9 ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anticorps monoclonaux ciblant l'IL-9 sont en développement pour traiter l'asthme."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes affectent-ils l'IL-9 ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire les niveaux d'IL-9 et l'inflammation associée."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés pour l'asthme lié à l'IL-9 ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les bronchodilatateurs et les corticostéroïdes sont couramment prescrits."
}
},
{
"@type": "Question",
"name": "L'immunothérapie aide-t-elle avec l'IL-9 ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'immunothérapie peut aider à moduler la réponse immunitaire liée à l'IL-9."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec l'IL-9 ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des exacerbations d'asthme et des réactions allergiques sévères."
}
},
{
"@type": "Question",
"name": "L'IL-9 peut-elle aggraver d'autres maladies ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 peut exacerber des maladies auto-immunes et inflammatoires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de surinfection ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients avec des niveaux élevés d'IL-9 peuvent être à risque de surinfections."
}
},
{
"@type": "Question",
"name": "Des complications pulmonaires sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'IL-9 peut contribuer à des complications pulmonaires comme la fibrose."
}
},
{
"@type": "Question",
"name": "L'IL-9 est-elle liée à des troubles cardiovasculaires ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études suggèrent un lien entre l'IL-9 et des troubles cardiovasculaires, mais c'est encore à étudier."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour l'IL-9 ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux d'allergies et d'asthme augmentent le risque d'IL-9 élevée."
}
},
{
"@type": "Question",
"name": "L'exposition à la pollution augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la pollution de l'air est un facteur de risque connu pour les maladies liées à l'IL-9."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il l'IL-9 ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut augmenter les niveaux d'IL-9 et aggraver les symptômes respiratoires."
}
},
{
"@type": "Question",
"name": "Les infections respiratoires sont-elles un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections respiratoires peuvent déclencher une réponse immunitaire impliquant l'IL-9."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur l'IL-9 ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut exacerber les symptômes et augmenter les niveaux d'IL-9."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 30/03/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
5 publications dans cette catégorie
Affiliations :
Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
4 publications dans cette catégorie
Affiliations :
Philochem AG, CH-8112 Otelfingen, Switzerland.
Publications dans "Interleukine-9" :
4 publications dans cette catégorie
Affiliations :
Philochem AG, CH-8112 Otelfingen, Switzerland.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Infectious Diseases, Medical Microbiology and Hygiene, Heidelberg University, Heidelberg, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Internal Medicine I, Univerisity Hospital Jena, 07747 Jena, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, Heinrich-Heine University Düsseldorf, 40225 Düsseldorf, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Internal Medicine I, Univerisity Hospital Jena, 07747 Jena, Germany.
Publications dans "Interleukine-9" :
3 publications dans cette catégorie
Affiliations :
Department of Internal Medicine I, Univerisity Hospital Jena, 07747 Jena, Germany.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Microbiology, Immunology and Parasitology Department, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
College of Veterinary Medicine, Yangzhou University, Yangzhou, China.
Institute of Comparative Medicine, Yangzhou University, Yangzhou, China.
Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonosis, Yangzhou University, Yangzhou, China.
International Corporation Laboratory of Agriculture and Agricultural Products Safety, Yangzhou University, Yangzhou, China.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Rheumatology, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Orthopaedics, All India Institute of Medical Sciences, New Delhi 110029, India.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publications dans "Interleukine-9" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Brown Center for Immunotherapy, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Publications dans "Interleukine-9" :
To explore the impact of gender mismatch on corneal allograft rejection and rejection-related graft failure in patients with repeat penetrating keratoplasty (PK)....
A retrospective cohort was conducted at Ramathibodi Hospital, Bangkok, Thailand. Patients with repeat PK and follow-up period of at least 6 months were recruited. Demographic data, pre-operative ocula...
Of 68 patients with repeat PK, 26 patients (38.2%) were gender mismatched. There was no difference in 3-year rejection-free survival and graft survival between patients with gender mismatch and others...
Gender mismatch might not impact corneal graft rejection or rejection-related graft failure in patients with repeat PK. Younger age was found to be a strong factor associated with graft rejection. Gen...
We aimed to investigate the clinical characteristics and risk factors for graft rejection after keratoplasty in Japanese patients. We enrolled 730 cases (566 patients) of penetrating keratoplasty (PK,...
Acute rejection (AR) is a process triggered...
To report a case of epithelial downgrowth after penetrating keratoplasty....
A 58-year-old man presented with graft rejection in his three-month-old, repeat penetrating keratoplasty. Examination revealed centripetal opacification of the posterior cornea due to deep epithelizat...
Epithelial downgrowth is an uncommon complication of penetrating keratoplasty. It affects the patients' visual acuity and graft survival. Clinical observation is preferred in severe cases due to the h...
The aim of the study was to present the rates of rejection from 2018 to 2021 and evaluate the purported association between COVID-19 vaccination and corneal graft rejection....
Cases of corneal graft rejection diagnosed between January 2018 and December 2021 were reviewed. The conditional Poisson regression model of the self-controlled case series method was used to estimate...
Over the past 4 years, the annual tally of diagnosed cases of graft rejection (19 cases in year 2018, 19 cases in year 2019, 21 cases in year 2020, and 18 cases in year 2021) has remained relatively s...
No notable increase in rates of corneal graft rejection was noted in year 2021 when COVID-19 vaccination was broadly implemented. The apparent temporal relationship between COVID vaccination and corne...
To evaluate the association between donor-related factors and the risk of rejection in patients undergoing penetrating keratoplasty (PKP) for keratoconus....
A retrospective review was performed of keratoconus patients with no corneal neovascularization who underwent PKP from November 2014 to December 2016 and completed at least two years of follow-up. Pre...
A total of 201 eyes (of 201 patients) that underwent PKP for keratoconus were included. Of these, 22.9% (95% CI 17.6-29.2%) had an episode of graft rejection. The overall graft survival rate was 98.5%...
In the multivariable analysis, none of the donor-related factors were significantly associated with graft rejection; however, short death-to-surgery time may be associated with rejection after PKP. Re...
There are few predictive studies about early posttransplant outcomes taking into account baseline and posttransplant variables. The objective of this study was to create a predictive model for 30-day ...
Retrospective study with 1255 patients undergoing transplant from living and deceased donors at a tertiary health service in Brazil. Recipient, donor, transplantation, and postoperative period data we...
There were 147 (12.48%) cases of graft rejection within 30 days of transplantation. The best model was XGBoost (accuracy, 0.839; receiver operating characteristic area under the curve, 0.715; precisio...
We fitted a machine learning model to predict 30-day graft rejection after kidney transplantation that reaches a higher accuracy and precision. Machine learning models could contribute to predicting k...
Microvasculature consisting of endothelial cells and pericytes is the main site of injury during antibody-mediated rejection (ABMR) of renal grafts. Little is known about the mechanisms of activation ...
Rejection is one of the major factors affecting the long-term prognosis of kidney transplantation, and timely recognition and aggressive treatment of rejection is essential to prevent disease progress...
The complement system, consisting of more than thirty different soluble and cell-bound proteins, exerts essential functions both in the innate and adaptive immune systems and is believed to be an impo...
In this case-control feasibility study, complement factors C3a, C3dg, C4a, and C5a were measured in plasma and C3dg and sC5b-9 associated C9 neoantigen in urine in 15 kidney transplant recipients with...
In plasma, there were no significant differences between the rejection and the control group. However, steroids and pretransplant C3dg levels significantly influenced C3dg. Within the rejection group,...
This study shows increased plasma C3a and C3dg in kidney transplant recipients, primarily with T cell mediated rejection. This finding suggests that consecutive measurements of C3a and C3dg in plasma ...